VXRT · Forms 3, 4, 5
Insider trades at Vaxart, Inc.
No open-market insider buys or sells at Vaxart, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Vaxart, Inc. (VXRT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Vaxart, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kevin Finney | Director | Award | 39,400 | Form 4 | |||
| James B Breitmeyer | Director | Award | 8,315 | Form 4 | |||
| Elaine J Heron | Director | Award | 39,400 | Form 4 | |||
| W. Mark Watson | Director | Award | 39,400 | Form 4 | |||
| David E. Wheadon | Director | Award | 39,400 | Form 4 | |||
| W. Mark Watson | Director | Buy | 10,000 | $0.65 | $7K | Form 4 | |
| Jeroen Nicolaas Grasman | Chief Financial Officer | Tax withholding | 31,395 | $0.61 | $19K | Form 4 | |
| James B Breitmeyer | Director | Became an insider (Form 3) | Form 3 | ||||
| James B Breitmeyer | Director | Award | 78,800 | Form 4 | |||
| Sean Tucker | SVP, Chief Scientific Officer | Tax withholding | 3,924 | $0.65 | $3K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.